Incidence of pruritus during and after intensive care

Recruiting

• Conditions: Itch/pruritus; L29.9; L29.8; Pruritus, unspecified; Other pruritus

• Registration Number: DRKS00022451
• Lead Sponsor: Klinik für Anästhesiologie, Intensiv- und Schmerzmedizin, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil Bochum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-08-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

Age = 18 years, written informed consent, sufficient knowledge of German, need for intensive care

Exclusion Criteria

Employees of the investigators or of the institution who are involved in the conduct of this or other clinical trials, participants who are unable to provide informed consent due to languae, psychological or somatic reasons; secondary: poor health (e.g. ventilation, sedation)

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prospective evaluation of the pruritus incidence during the first seven days of intensive care therapy: objectively through observation by the examiner, subjectively through filling out questionnaires.

Secondary Outcome Measures

Name	Time	Method
Incidence of pruritus during and 1-week, 3-months, 1-year after intensive care, assessment of the severity of newly occuring pruritus, impact on quality of life.